由弗莱卡尼尼德诱导的先进心房间间隔阻塞
Jillian Hall1, Daniel Edmundowicz1, Edmond Cronin1
1Section of Cardiology, Department of Medicine, Lewis Katz School of Medicine at Temple University, Philadelphia, PA, United States of America.
Journal of electrocardiology
|August 28, 2024
概括
弗莱卡尼德的毒性会导致先进的心房间隔膜阻塞,严重的心脏导电异常. 这一案例凸显了在弗莱卡尼尼德治疗期间监测心脏功能的必要性.
科学领域:
- 心脏病学 心脏病学
- 电子生理学 电子生理学
- 药理学 药理学是指药理学的学科.
背景情况:
- 心室间阻塞是心房之间的电导延迟.
- 弗莱卡因是一种抗心律失常药物,具有潜在的前心律失常效应.
- 药物毒性可以表现为新的导电异常.
研究的目的:
- 报告一个罕见的先进心房间间隔阻塞病例.
- 要将这种导电异常归因于弗莱卡因的毒性.
- 讨论弗莱卡尼德诱导的心脏间阻塞的临床影响.
主要方法:
- 案例报告的呈现方式.
- 审查患者的临床病史和药物治疗.
- 电心电图分析以确定导电异常.
主要成果:
- 患者在施用弗莱卡因尼德后出现了先进的心房间隔膜阻塞.
- 弗莱凯尼德毒性被确定为引起因素.
- 间阻塞代表了显著的导电延迟.
结论:
- 弗莱卡因胺的毒性可以诱导先进的心房间隔膜阻塞.
- 这种导电异常具有显著的临床影响.
- 在接受 flecainide 治疗的患者中,必须进行仔细的监测.
相关概念视频
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
935
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
935
Disturbances in Heart Rhythm
919
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
919
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
1.3K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.3K
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
719
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
719
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
798
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
798
Mechanism of Cardiac Arrhythmias
901
Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
901


